1. Home
  2. SLS vs ALCO Comparison

SLS vs ALCO Comparison

Compare SLS & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • ALCO
  • Stock Information
  • Founded
  • SLS 2012
  • ALCO 1960
  • Country
  • SLS United States
  • ALCO United States
  • Employees
  • SLS N/A
  • ALCO N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • ALCO
  • Sector
  • SLS Health Care
  • ALCO
  • Exchange
  • SLS Nasdaq
  • ALCO Nasdaq
  • Market Cap
  • SLS 238.7M
  • ALCO 267.7M
  • IPO Year
  • SLS N/A
  • ALCO N/A
  • Fundamental
  • Price
  • SLS $1.51
  • ALCO $32.95
  • Analyst Decision
  • SLS Strong Buy
  • ALCO
  • Analyst Count
  • SLS 1
  • ALCO 0
  • Target Price
  • SLS $7.00
  • ALCO N/A
  • AVG Volume (30 Days)
  • SLS 5.3M
  • ALCO 21.7K
  • Earning Date
  • SLS 11-07-2025
  • ALCO 12-01-2025
  • Dividend Yield
  • SLS N/A
  • ALCO 0.60%
  • EPS Growth
  • SLS N/A
  • ALCO N/A
  • EPS
  • SLS N/A
  • ALCO N/A
  • Revenue
  • SLS N/A
  • ALCO $44,199,000.00
  • Revenue This Year
  • SLS N/A
  • ALCO N/A
  • Revenue Next Year
  • SLS N/A
  • ALCO N/A
  • P/E Ratio
  • SLS N/A
  • ALCO N/A
  • Revenue Growth
  • SLS N/A
  • ALCO N/A
  • 52 Week Low
  • SLS $0.77
  • ALCO $24.76
  • 52 Week High
  • SLS $2.48
  • ALCO $35.90
  • Technical
  • Relative Strength Index (RSI)
  • SLS 32.03
  • ALCO 41.63
  • Support Level
  • SLS $1.85
  • ALCO $32.23
  • Resistance Level
  • SLS $2.06
  • ALCO $35.39
  • Average True Range (ATR)
  • SLS 0.14
  • ALCO 0.76
  • MACD
  • SLS -0.06
  • ALCO -0.28
  • Stochastic Oscillator
  • SLS 0.00
  • ALCO 23.51

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

Share on Social Networks: